The global gastroesophageal reflux disease (GERD) devices industry size exhibited significant growth at the close of 2021, marking a valuation of approximately US$ 1.12 Billion, The global GERD devices market is expected to reach a valuation of US$ 1.17 Billion in 2022. A comprehensive market analysis indicates a promising trajectory ahead, with projections foreseeing a …
Category Archives: Healthcare Trends
Global Urology Imaging Systems Industry is forecasted to attain a valuation of US$ 486.4 Million by 2028 | FMI
In a groundbreaking projection, the global urology imaging systems industry demand is poised to reach unprecedented heights, with anticipated sales set to surpass US$ 486.4 million by 2028, growing at a robust 3.7% CAGR from US$ 391.6 million in 2022. The forecasted surge owes itself to an amalgamation of factors driving the market’s trajectory. The …
Global Tattoo Removal Lasers Industry is expected to surge to US$ 328.5 Million by 2028, buoyed by technological advancements and rising demand | FMI
Sales of tattoo removal lasers industry demand are predicted to increase, rising by 5.7% CAGR from US$ 235.2 million in 2022 to US$ 328.5 million by 2028. The Tattoo Removal Lasers market is anticipated to register enticing revenue growth in the upcoming years. The market value share of tattoo parlours is expected to increase over …
Global Weight Loss and Obesity Management Industry reaching a value of US$ 4.99 Billion by 2028 | FMI Study
The global weight loss and obesity management industry size is expected to have a net worth of US$ 3.68 billion in 2022 and to grow at a CAGR of 5.2% to reach US$ 4.99 billion by value by 2028. One of the most urgent health issues of our time is being addressed by the weight …
Global Generic Oncology Drugs Industry is on the brink of considerable expansion, with an anticipated value of US$ 34.8 Billion by 2028
Sales of generic oncology drugs industry size are anticipated to reach US$ 24.5 billion in 2022 and US$ 34.8 billion by the end of 2028, rising at a 6% CAGR. The main factor causing cancer in people is the rise in tobacco use and smoking. The human body is vulnerable to cancer due to secondary …
Global Sleep Aid Devices Industry is poised for substantial growth, with projections showing a 6.9% CAGR by 2032 tracked by FMI
According to projections, the global sleep aid devices industry demand will be worth roughly US$ 68354.36 million in 2022 and US$ 133211.98 million by 2032. The market is anticipated to expand at a 6.9% CAGR from 2022 to 2032. As the prevalence of sleep problems and insomnia has continued to climb, the Sleep Aid Devices …
Global Oral Antiseptics Industry in North America and East Asia anticipates a stable 4.7% CAGR till 2028 | FMI
The global oral antiseptics industry size is set to witness an unprecedented surge, with projections indicating a substantial rise from a valued US$ 2.47 billion in 2022 to an estimated US$ 3.24 billion by 2028. This anticipated growth is substantiated by a promising Compound Annual Growth Rate (CAGR) of 4.7%. The Oral Antiseptics Market has …
Over-the-Counter Pain Medication Industry Poised for Skyrocketing Success, Targeting a US$ 27.7 Billion Valuation by 2028-FMI Report
The over-the-counter (OTC) painkillers industry is expected to reach US$ 21.8 billion in 2022, according to a recent analysis by Future Market Insights (FMI). The growth of this market is expected to be impacted by changing perceptions of generic prescription medications. The analysis projects that market sales would rise at a faster 4.1% annual pace …
Global Brain Monitoring Systems Industry is estimated at US$ 8.5 Billion by 2033, is highlighted by FMI
The global brain monitoring systems industry size is poised for substantial growth according to recent projections, with an anticipated rise at a Compound Annual Growth Rate (CAGR) of 5.5% from 2023 to 2033. These findings, unveiled in a comprehensive market analysis report, forecast the market to soar from a value of US$ 5.0 billion in …
Seasonal Affective Disorder Therapeutics Industry Radiant Growth on the Horizon, Anticipated to Achieve US$ 1.1 Billion by 2028-FMI Report
The research states that SSRIs, or selective serotonin reuptake inhibitors, are often prescribed drugs for the treatment of seasonal affective disorder. In the market for seasonal affective disorder treatments industry, there are numerous branded and generic drugs accessible, however Buproban and Citalopram continue to sell at a comparatively greater rate. FMI attributes this supremacy to …